Hematologic Malignancies News Today

100% of treated leukemia patients achieved durable complete remission at 1-year, including high-risk and relapsed acute myeloid leukemia patients who had previously failed multiple lines of...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

-- CB-010 allogeneic CAR-T cell therapy with partial HLA matching has potential to rival efficacy and safety profile of approved autologous CAR-T cell...

The majority of patients that responded to obe-cel showed durable responses with the potential for a long-term plateau of survival outcomes40% patients are in ongoing remission without subsequent stem...

New insights on improving clinical outcomes and quality of life among breast cancer patients highlight the slate of new research presentations Roswell Park

/PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated...

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and...

Innate Pharma SA annonce aujourd'hui que 5 abstracts concernant des candidats-médicaments d'Innate ont été sélectionnés pour le congrès annuel de...

Company to host conference call on Thursday, May 16, 2024 at 8:00 a.m. ETBOSTON and ATLANTA, May 15, 2024 -- Inhibikase Therapeutics, Inc. , a clinical-stage pharmaceutical company developing...

Company to host conference call on Thursday, May 16, 2024 at 8:00 a.m. ET...